About Dr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories Limited (DRREDDY) has been publicly traded since 1996, making it a 30-year-old public company. It operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. The company is headquartered in Hyderabad, India and employs approximately 27,811 people. With a market capitalization of $1.1 trillion, DRREDDY is one of the largest publicly traded companies.
Key Statistics
- Current Price
- ₹1,292.30
- Market Cap
- ₹1.08T
- 52-Week High
- ₹1,379.70
- 52-Week Low
- ₹1,020.00
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
₹1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +1.64% | ₹1,271.40 | ₹1,292.30 |
| 2025 | -7.85% | ₹1,379.75 | ₹1,271.40 |
| 2024 | +20.45% | ₹1,145.49 | ₹1,379.75 |
| 2023 | +37.89% | ₹830.71 | ₹1,145.49 |
| 2022 | -13.05% | ₹955.40 | ₹830.71 |
| 2021 | -5.29% | ₹1,008.81 | ₹955.40 |
| 2020 | +82.24% | ₹553.55 | ₹1,008.81 |
| 2019 | +10.70% | ₹500.03 | ₹553.55 |
| 2018 | +9.32% | ₹457.39 | ₹500.03 |
| 2017 | -20.53% | ₹575.53 | ₹457.39 |
| 2016 | -1.00% | ₹581.33 | ₹575.53 |
| 2015 | -3.72% | ₹603.81 | ₹581.33 |
| 2014 | +28.95% | ₹468.25 | ₹603.81 |
| 2013 | +39.43% | ₹335.82 | ₹468.25 |
| 2012 | +16.96% | ₹287.14 | ₹335.82 |
| 2011 | -4.41% | ₹300.39 | ₹287.14 |
| 2010 | +46.17% | ₹205.51 | ₹300.39 |
| 2009 | +146.62% | ₹83.33 | ₹205.51 |
| 2008 | -35.63% | ₹129.47 | ₹83.33 |
| 2007 | -9.22% | ₹142.62 | ₹129.47 |
| 2006 | +66.49% | ₹85.66 | ₹142.62 |
| 2005 | +13.76% | ₹75.30 | ₹85.66 |
| 2004 | -39.05% | ₹123.55 | ₹75.30 |
| 2003 | +59.82% | ₹77.30 | ₹123.55 |
| 2002 | -2.73% | ₹79.47 | ₹77.30 |
| 2001 | +44.94% | ₹54.83 | ₹79.47 |
| 2000 | -8.73% | ₹60.07 | ₹54.83 |
| 1999 | +186.31% | ₹20.98 | ₹60.07 |
| 1998 | +50.77% | ₹13.92 | ₹20.98 |
| 1997 | +105.66% | ₹6.77 | ₹13.92 |
Valuation
DRREDDY currently trades at a trailing P/E ratio of 19.0, which is considered moderate relative to the broader market. The forward P/E of 23.5 suggests analysts expect earnings to be higher in the coming year. The price-to-book ratio stands at 2.9. The price-to-sales ratio is 3.1.
Dividends
Dr. Reddy's Laboratories Limited pays a dividend to shareholders with a current yield of 0.62%. This translates to $8.00 per share annually. The payout ratio of 12% indicates sustainable dividend coverage.
Risk & Volatility
DRREDDY has a beta of 0.31, indicating it is less volatile than the overall market. The stock's 52-week range is $1020.00 to $1379.70, and it currently trades in the upper half of its 52-week range.
Analyst Ratings
Based on 38 analyst opinions, DRREDDY has a consensus "hold" rating. The average price target of $1312.56 suggests 1.6% upside from current levels.
Frequently Asked Questions
What does Dr. Reddy's Laboratories Limited do? ▼
Dr. Reddy's Laboratories Limited is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector. The company is headquartered in Hyderabad, India.
What sector is DRREDDY in? ▼
DRREDDY operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
When did DRREDDY go public? ▼
Dr. Reddy's Laboratories Limited went public in 1996, making it a 30-year-old public company as of 2026.
How much would $1,000 invested in DRREDDY 5 years ago be worth today? ▼
A $1,000 investment in DRREDDY five years ago would be worth approximately $1,376 today, representing a 37.6% return.
Does DRREDDY pay dividends? ▼
Yes, Dr. Reddy's Laboratories Limited pays a dividend with a current yield of 0.62%, which is $8.0 per share annually.
What is DRREDDY's market cap? ▼
Dr. Reddy's Laboratories Limited has a market capitalization of $1.1 trillion, classifying it as a mega-cap company.
What is DRREDDY's P/E ratio? ▼
DRREDDY has a trailing P/E ratio of 19.0 and a forward P/E of 23.5, which measures how much investors are paying per dollar of earnings.
Is DRREDDY a buy, hold, or sell? ▼
Based on 38 opinions, DRREDDY has a consensus "hold" rating. The average price target is $1312.56.
Last updated: 3/14/2026